← Back
World

Briefing: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales

Strategic angle: Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug.

Editorial Staff1 min

Summary

  • Summary pending editorial review.

Key Facts

  • Key facts pending editorial review.

Sources